Case Report: Bullous erythema multiforme induced by omalizumab

• by Zenan Tang, Yan Zhao

• July 17, 2026

Connected Health May Match In-Person AD Care

A randomized clinical trial found that a team-based connected health model achieved equivalent improvements in atopic dermatitis severity and symptoms compared with conventional in-person care over 12 months.

• by Andrea Surnit

• July 9, 2026

• 3 min

Chronic Spontaneous Urticaria (CSU) in Chinese Patients: Real-World Evidence of Disease Control and Treatment Patterns from the Urticaria Voices Study

• by Zuotao Zhao, Yi Li, Tara Raftery, Nadine Chapman-Rothe, Pallavi Saraswat, Jessica McCarthy, Ravneet Kaur Kohli, Cristina Constantinescu, Angie Li, Guojiao You, Ruixin Tan, Bin Yang

• July 15, 2026

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial

• by Philip J. Mease, Vinod Chandran, April W. Armstrong, Ricardo Blanco, Alexis Ogdie, Evan L. Siegel, Alice B. Gottlieb, Xiaofeng Zeng, Diamant Thaçi, Mitsumasa Kishimoto, Hendrik Schulze-Koops, Alan Kivitz, Eva Dokoupilová, Akimichi Morita, Eric M. Ruderman, Michael Plewinski, Kejia Wang, Caroline Sardinas, Eleni Vritzali, John Vaile, Atul Deodhar

• July 20, 2026